Aspirin and Probenecid Inhibit Organic Anion Transporter 3–Mediated Renal Uptake of Cilostazol and Probenecid Induces Metabolism of Cilostazol in the Rat-Reference-Cited by-同舟云学术

Aspirin and Probenecid Inhibit Organic Anion Transporter 3–Mediated Renal Uptake of Cilostazol and Probenecid Induces Metabolism of Cilostazol in the Rat

Published:2014-04-01 Issue:6 Volume:42 Page:996-1007
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Wang Chong,Wang Changyuan,Liu Qi,Meng Qiang,Cang Jian,Sun Huijun,Peng Jinyong,Ma Xiaochi,Huo Xiaokui,Liu Kexin

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference37 articles.

1. Toward a Systems Level Understanding of Organic Anion and Other Multispecific Drug Transporters: A Remote Sensing and Signaling Hypothesis

2. Cytochrome P450 3A and 2B6 in the developing kidney: implications for ifosfamide nephrotoxicity

3. Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man

4. Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of Cilostazol

5. In Vitro and In Vivo Evidence of the Importance of Organic Anion Transporters (OATs) in Drug Therapy

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of proteasome, but not lysosome, upregulates organic anion transporter 3 in vitro and in vivo;Biochemical Pharmacology;2023-02

2. Discovery of novel benzbromarone analogs with improved pharmacokinetics and benign toxicity profiles as antihyperuricemic agents;European Journal of Medicinal Chemistry;2022-11

3. JBP485, A Dual Inhibitor of Organic Anion Transporters (OATs) and Renal Dehydropeptidase-I (DHP-I), Protects Against Imipenem-Induced Nephrotoxicity;Frontiers in Pharmacology;2022-06-08

4. The Prescription of Drugs That Inhibit Organic Anion Transporters 1 or 3 Is Associated with the Plasma Accumulation of Uremic Toxins in Kidney Transplant Recipients;Toxins;2021-12-25

5. Transporter-mediated drug–drug interactions: advancement in models, analytical tools, and regulatory perspective;Drug Metabolism Reviews;2021-06-02